Harbottle R, Richardson S J
Biochem J. 1984 Jan 15;217(2):485-91. doi: 10.1042/bj2170485.
2-Thiouracil and a number of its alkyl derivatives are known to inhibit the enzymic 5'-deodination of thyroxine to 3,5,3'-tri-iodothyronine. The structural requirements for inhibition of iodothyronine 5'-deiodinase were investigated by using a washed postmitochondrial particulate fraction of human liver. A series of sulphur-containing derivatives of pyrimidine, pyridine, imidazole, benzene and urea, capable of existing in a thiol form, were incubated at several concentrations with the enzyme preparation in the presence of thyroxine and dithioerythritol (cofactor). The degree of inhibition by the respective compounds of the production of 3,5,3'-tri-iodothyronine was studied in relation to their structural features. The major observations were: (i) a free thiol group is essential; (ii) compounds that do not possess a polar hydrogen atom spatially configured so that it is proximal to the thiol group are poor inhibitors; (iii) aromatic characteristics in the presence of requirements (i) and (ii) lead to the expression of potent inhibitory properties; (iv) modification of potent inhibitors by the introduction of hydrophilic substituents reduces the inhibitory potency.
已知2-硫尿嘧啶及其多种烷基衍生物可抑制甲状腺素向3,5,3'-三碘甲状腺原氨酸的酶促5'-脱碘作用。利用人肝洗涤后的线粒体后颗粒组分,研究了抑制碘甲状腺原氨酸5'-脱碘酶的结构要求。一系列能够以硫醇形式存在的嘧啶、吡啶、咪唑、苯和尿素的含硫衍生物,在甲状腺素和二硫苏糖醇(辅助因子)存在的情况下,与酶制剂以几种浓度进行孵育。研究了各化合物对3,5,3'-三碘甲状腺原氨酸生成的抑制程度与其结构特征的关系。主要观察结果如下:(i)一个游离硫醇基团至关重要;(ii)不具有空间构型使其靠近硫醇基团的极性氢原子的化合物是较差的抑制剂;(iii)在满足要求(i)和(ii)的情况下,芳香特性导致强效抑制特性的表达;(iv)通过引入亲水性取代基对强效抑制剂进行修饰会降低抑制效力。